openPR Logo
Press release

A Big Pharma update on Fighting Superbugs: GSK Report Industry Developments in Addressing AMR

01-10-2017 01:09 PM CET | Health & Medicine

Press release from: SMi Group

SMi Group will welcome the expertise of James Anderson, Head of Corporate Affairs from GlaxoSmithKline, who will be providing attendees at the 19th annual Superbugs and Superdrugs show with an exclusive update on how the pharmaceutical industry is helping address anti-microbial resistance (AMR).

A recent report by Public Health England revealed that FEWER antibiotics are being prescribed by GPs and clinicians for the first time.* However there is still a lot of work to be done. What else is the industry doing beyond investing in R&D for new antibiotics? * Source: http://bit.ly/2fx6MtL

The GSK keynote address will delve further into key topics surrounding partnerships with healthcare systems to ensure sterile manufacturing, antibiotic stewardship and new economic models for sustainable solutions.

He will be joined in London this March by a notable speaker line up including:

• Sumathi Nambiar, Director, Division of Anti-Infective Products, FDA
• Richard Bax, Senior Partner, TranScrip
• Lloyd Czaplewski, Director, Chemical Biology Ventures
• Chris Houchens, Branch Chief, BARDA
• Aileen Rubio, Head of Biology, Spero Therapeutics
• David Williams, Chief Executive Officer, Discuva
• Martin Everett, Chief Scientific Officer, ANTABIO SAS
• Jean de Gunzburg, Scientific Director, Da Volterra
• William J Weiss, Director, Pre-Clinical Services, UNT System College of Pharmacy
• Xavier Duportet, CEO, Eligo Bioscience

Further details including a detailed conference agenda and full speaker line-up is available at www.superbugssuperdrugs.com

Superbugs & Superdrugs 2017
20TH & 21ST March
Copthorne Tara Hotel, London, UK
http://www.superbugssuperdrugs.com

--end –

Contact Information:

For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
For delegate enquires contact Fateja Begum on Tel: +44 (0)20 7827 6184 / Email: fbegum@smi-online.co.uk
For exhibition and sponsorship enquires contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
tarri@smi-online.co.uk
+44 (0)20 7827 6162
2 Floor Harling House
47-51 Great Suffolk Street

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A Big Pharma update on Fighting Superbugs: GSK Report Industry Developments in Addressing AMR here

News-ID: 409298 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Director

Boys & Girls Club Announces New Director of Major Gifts & Resource Development a …
The Boys & Girls Clubs of Greater Oxnard and Port Hueneme announce two new employees, Nicole Eads is the new director of major gifts and resource development; and Ashley Lyden is the new director of operations. “Nicole and Ashley both bring great experience in working with youth and nonprofits,” said Erin Antrim, CEO BGCOP. “They are passionate about helping the youth in our community and will be great additions to our
Wallace Associates: Director of Sales
Director of Sales San Francisco, CA or New York, NY The Company Our client helps the world’s media, information, and technology providers grow revenue, deliver superior solutions, optimize their clients’ performance, and thrive in a fast-changing global digital market. Our client advances the business of information as a company “that works” — for each other, their clients, their stakeholders, and their community. The Job Our client is looking for a proven top-producer, entrepreneurial-minded, highly motivated,
Songwon appoints KY Lee as Managing Director for Korea and Sales Director for No …
Ulsan, Korea – April 24, 2012 – KY Lee will join the Songwon team as Managing Director (상무, 'sangmoo') for Korea and Sales Director for North East Asia from the 2nd of May, 2012. Songwon Industrial Co. Ltd., the global number two supplier of polymer additives, has created this new key role within their Global Sales and Technical Service organization to reflect the importance of this key region and market.
S2S appoints Director of Logistics
London, 16th January 2012 - Martin Lyon has been appointed Director of Logistics & Supply Chain Development for management and investment company S2S Group’s new supply chain operation. S2S’s newly formed 4PL enterprise is the first operator able to offer complete end-to-end supply chain services in the Middle East. The appointment supports S2S as it establishes itself in the market and develops its innovative 4PL logistics operation. He will be based in
OGT Appoints New Finance Director
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced the appointment of a new finance director as part of the company’s ongoing rapid growth and expansion. Mr Tim Hall will join the company at the start of 2012 and brings a strong track record in financial management and strategic planning together with a broad knowledge of the biotech and healthcare
New Sales Director at IXXAT
Thomas Waggershauser is the new Sales Director at IXXAT Automation GmbH. In his new position, Thomas Waggershauser (34) is responsible for the sales activities of IXXAT and the development and expansion of the existing international distributors. Mr. Waggershauser has been employed at IXXAT Automation GmbH as a Sales Engineer since 2004, with responsibility for CAN and Automotive Systems. Before this he was a Product Manager for remote maintenance systems und signal generators